A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
Clinical trial NCT06143878 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06143878
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-01
- Primary completion
- 2024-09-17
- Enrollment
- 774
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.